^

Original-Research: INDUS Holding AG - from NuWays AG

13.11.2024 / 09:01 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group AG.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to INDUS Holding AG

Company Name: INDUS Holding AG

ISIN: DE0006200108

Reason for the research: Update

Recommendation: Buy

from: 13.11.2024

Target price: EUR 34.00

Target price on sight of: 12 months

Last rating change:

Analyst: Christian Sandherr

Final Q3 results out // 2nd buyback offer announced; chg. est.

Topic: INDUS released its final Q3 numbers in line with preliminary results.

Even more importantly, the company announced a public buyback offer in the

period from 12-25 November 2024 up to EUR 15.2m.

To recap: Q3 sales decreased slightly by 3.6% to EUR 443m due to a challenging

macro environment and low order backlog. Reported EBIT remained roughly

unchanged yoy at a solid EUR 31.8m with a 7.2% EBIT margin. However, adjusted

for impairments of EUR 6.7m in Q3'24 and EUR 17.6m in Q3'23, EBIT decreased by

22%. Personnel costs increased slightly by 0.6% yoy to EUR 129.4m despite a

lower headcount (-1.6% yoy of continuing operations) due to a notable rise

in wages and salaries. Cost of materials increased 1.4% yoy to EUR 195m with a

1.3pp increase in the cost ratio from a low comparable base.

Order intake remained unchanged yoy at EUR 392m (EUR 391 in Q3'23) but on a low

level due to a weak economic situation in the metal production and

processing sectors. This leads to an order backlog of EUR 678m (vs. EUR 711m end

of FY23). While the demand situation stopped declining and consolidated now

on a low level (EUR 1,220m order intake 9M'24 vs. EUR 1,230m in 9M'23), the book

to bill ratio is still slightly below 1.00 (0.95 in 9M'24). However, we

estimate that INDUS has already overcome the low point, and we should see

successive improvements for FY25e.

Buyback offer announced: already in February, INDUS acquired 1.1m shares at

a price of EUR 23 per share in a public buyback offer, amounting to 4.1% of

its share capital, which are still held as treasury shares. The company

announced now a second buyback offer at EUR 21.65 per share for 0.7m shares in

the period from 12-25 November. In addition, INDUS intends to buy for up to

EUR 5m, but no more than 0.2m shares on the open market between 2 December

2024 at the earliest and until 16 May 2025 at the latest. If both programs

are conducted successfully, INDUS would hold up to 7.4% in treasury shares.

According to management, shares from the second tender offer and the open

market transaction will be cancelled. This is positive news, as the stock is

clearly undervalued in our view and hence repurchasing shares offers an

attractive return on invested capital compared to other capital allocation

choices.

Strong FCF: management confirmed the FCF outlook for FY24e of above EUR 110m.

INDUS achieved EUR 71.9m FCF in 9M'24, EUR 34.2m lower than last year but still

on a solid level. Further, FCF in 9M'23 includes a positive one-time effect

of EUR 14.4m from a property sale. The FY target of EUR 110m looks plausible in

our view (eNuW: EUR 115m), as working capital tends to come down in Q4 due to

seasonal effects. With that, INDUS should deliver a strong FCFY'24e of c.

10%.

2025 outlook: According to management, the geopolitical and macroeconomic

challenges should continue to exist in FY25e. However, compared to Q1'24,

the situation has already visible improved. Thus, we expect to see a

moderate top-line improvement for FY25e of 5.4% to EUR 1810m, of which EUR

40-50m should be contributed from M&A acquisitions in FY24e and FY25e as

stated by management. Further, we expect EBIT to improve disproportionately

to EUR 150m in FY25e (eNuW) due to less expected impairments and macroeconomic

improvements.

Nevertheless, INDUS has shown resilience even in an adverse business

environment. On top of that, INDUS is trading at only 8x forward P/E (eNuW),

offers an expected dividend yield of 5.8% (eNuW FY24e: EUR 1.2 per share), and

delivers a strong FCFY24e of c. 10% (eNuW). Hence, we keep INDUS as one of

NuWays' Alpha Picks and reiterate BUY with an unchanged PT of EUR 34, based on

FCFY'24e.

You can download the research here: http://www.more-ir.de/d/31299.pdf

For additional information visit our website: www.nuways-ag.com/research

Contact for questions:

NuWays AG - Equity Research

Web: www.nuways-ag.com

Email: research@nuways-ag.com

LinkedIn: https://www.linkedin.com/company/nuwaysag

Adresse: Mittelweg 16-17, 20148 Hamburg, Germany

++++++++++

Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss

bestimmter Börsengeschäfte.

Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben

analysierten Unternehmen befinden sich in der vollständigen Analyse.

++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---------------------------------------------------------------------------

2028595 13.11.2024 CET/CEST

°